Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Jaguar Health (JAGX) EBT Margin (2016 - 2025)

Jaguar Health (JAGX) has disclosed EBT Margin for 11 consecutive years, with 234.97% as the latest value for Q3 2025.

  • On a quarterly basis, EBT Margin fell 652.0% to 234.97% in Q3 2025 year-over-year; TTM through Sep 2025 was 261.83%, a 18959.0% increase, with the full-year FY2024 number at 335.79%, up 9348.0% from a year prior.
  • EBT Margin was 234.97% for Q3 2025 at Jaguar Health, up from 268.28% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 143.2% in Q4 2024 to a low of 234683.33% in Q2 2021.
  • A 5-year average of 15208.78% and a median of 404.74% in 2023 define the central range for EBT Margin.
  • Peak YoY movement for EBT Margin: plummeted -23439164bps in 2021, then surged 23436187bps in 2022.
  • Jaguar Health's EBT Margin stood at 688.37% in 2021, then skyrocketed by 64bps to 251.21% in 2022, then plummeted by -61bps to 404.74% in 2023, then soared by 65bps to 143.2% in 2024, then plummeted by -64bps to 234.97% in 2025.
  • Per Business Quant, the three most recent readings for JAGX's EBT Margin are 234.97% (Q3 2025), 268.28% (Q2 2025), and 478.59% (Q1 2025).